Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of linagliptin 5 mg vs Trajenta 5 mg in healthy Thai volunteers under fasting conditions
TCTR20221206006Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of linagliptin (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
linagliptin
Beyond the preview
Go deeper on TCTR20221206006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221206006.